Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

7.94
+0.04000.51%
Post-market: 7.75-0.1900-2.39%17:08 EDT
Volume:2.15M
Turnover:17.01M
Market Cap:2.49B
PE:-188.60
High:8.02
Open:7.88
Low:7.76
Close:7.90
Loading ...

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Production Expansion and Manufacturing Collaboration

Stock Track
·
09 May

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Major Manufacturing Expansion Plans

Stock Track
·
09 May

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (Bfs) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

THOMSON REUTERS
·
08 May

Amneal Pharma: New Infrastructure Is Expected to Have Capacity to Produce Approximately 250 to 300 Mln Units Annually

THOMSON REUTERS
·
08 May

Truist Financial Remains a Buy on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
05 May

Amneal Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
02 May

Amneal Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Affirmed

MT Newswires Live
·
02 May

GUIDANCE: (AMRX) Amneal Pharmaceuticals Expects Full Year 2025 Net Revenue Range $3.0B - $3.1B, vs. FactSet Est of $3.03B

MT Newswires Live
·
02 May

BRIEF-Amneal Pharmaceuticals Q1 Revenue USD 695.42 Million

Reuters
·
02 May

Amneal Pharma: Affirming 2025 Full Year Guidance

THOMSON REUTERS
·
02 May

Amneal Pharmaceuticals Q1 Pretax Profit USD 37.486 Million

THOMSON REUTERS
·
02 May

Amneal Pharma: Q1 Adj EPS $0.21

THOMSON REUTERS
·
02 May

Amneal Pharmaceuticals Q1 Gross Profit USD 255.891 Million

THOMSON REUTERS
·
02 May

Amneal Pharmaceuticals Inc expected to post earnings of 15 cents a share - Earnings Preview

Reuters
·
30 Apr

3 Profitable Stocks Skating on Thin Ice

StockStory
·
29 Apr

Amneal Donates $1.5 Million to Support Patients During Parkinson’s Awareness Month

Business Wire
·
11 Apr

Amneal Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk

Dow Jones
·
10 Apr

Press Release: Amneal to Report First Quarter 2025 Results on May 2, 2025

Dow Jones
·
09 Apr

BRIEF-Amneal Announces New Data From Phase 3 Study

Reuters
·
07 Apr

Amneal Pharmaceuticals Inc - Crexont Improves Pdss-2 Scores by -2.35

THOMSON REUTERS
·
07 Apr